ASCO 2024 abstracts release today - Check out our ASCO investor tool
📣 Big day Today for ASCO 2024
Abstracts released and embargo lifted today at 5PM ET.
Our team has been busy creating our ASCO investor tools 👇
We’ve been importing all the abstract info
We will add actual abstracts after they are available
We’ve been scouring press releases for smid-cap readouts at ASCO
Thus far, we’ve identified ~50 ASCO smid-cap clin trial readouts (see Figs below 📸)
To find biopharma smid-caps that are most likely to be ASCO movers
FIG. 1. Phase 1 data readouts.
FIG. 2. Phase 1/2 data readouts.
FIG. 3. Phase 2/3 data readouts.
Here are the links to our ASCO free tools:
Get access to our full ASCO 2024 investor tools ⛏️
Become an Elite subscriber today!
🚨 40% ASCO special ends soon 🚨 👉 CLICK HERE to sign up today!
---------------------------------
This article is not investment, tax, or legal advice. Please do your own diligence and seek advice from professional advisors representing your interests.
Article history:
First published 05/23/24 JR & EJV